Investing.com推广文推荐Zoetis并称估值上行空间61.3%

Brent tops $95 for first time since June 11 amid widening Mideast conflict
Investing.com — As investors brace for another pivotal week of earnings from companies including Alphabet, Intel and Texas Instruments, much of the market’s attention remains fixed on the AI trade and whether the sector can justify its lofty expectations.
But while capital continues to chase the AI trade again, InvestingPro members, who subscribed for LESS THAN $7 a month as part of our Summer Sale, are already positioned across a growing number of high-conviction companies trading at steep discounts to their intrinsic value.
InvestingPro’s flagship ProPicks AI delivers an AI-powered list of high-conviction stock picks every month, driven by over 150 fundamental inputs and optimized to adapt to real-time market conditions.
Combined with InvestingPro’s Fair Value data — which aggregates 17 institutional-grade valuation models — premium members have access to dozens of high-quality picks trading at up to 75% below their estimated fair value.
The results reveal several businesses that have been overlooked amid the market’s relentless focus on AI. Here is a preview of the deeply undervalued setups flagged by the system:
- Zoetis (NYSE:ZTS): picked in June, is pointing to +61.3% Fair Value upside (Featured Spotlight Below)
- [LOCKED CONSULTING GIANT]: +62.9% Fair Value upside (InvestingPro Members Only)
- [LOCKED SOFTWARE GIANT]: +49.6% Fair Value upside (InvestingPro Members Only)
Among dozens more high-conviction value setups!
Want to see the full list of undervalued stocks and ProPicks AI selections? InvestingPro members can access July’s complete set of AI-powered stock picks HERE.
Still not a member? Then here’s your chance to get the full list of picks NOW:
High Fair Value upside is just one part of the InvestorPro edge. By catching undervalued quality right before the market re-rates it, premium members are locking in huge winners every month. Here are just a few of July’s standout performers so far:
- PBF Energy (NYSE:PBF): +37.49% in July ALONE (+57.90% since picked)
- Venture Global (NYSE:VG): +27.47% in July ALONE
- Delek US Energy (NYSE:DK): +26.44% in July ALONE (+78.47% since picked)
- Dorian LPG (NYSE:LPG): +26.40% in July ALONE
- HF Sinclair (NYSE:DINO): +26.36% in July ALONE
Among more than 20 double-digit winners!
Where market weakness meets accelerating commercial growth
Zoetis Inc (NYSE:ZTS) is a prime example of a fundamental disconnect between short-term market sentiment and long-term business quality. The world’s leading animal health provider has created a strong rebound setup. While the stock trades near 52-week lows at $76.20 (12x P/E), the company’s underlying fundamentals tell a completely different story. Commercial momentum is building rapidly following fresh regulatory approvals for Lenivia—its next-generation long-acting pain treatment for dogs—alongside a +17% surge in international sales driven by blockbuster treatments like Simparica Trio.
With a 2.8% dividend yield and an overall "Great" financial health, InvestingPro places Zoetis’s Fair Value at $122.88 (+61.3% upside). Wall Street consensus agrees, with analyst price targets averaging $114.76 (+50.6% upside).
What our models identified
Our ML engine flagged Zoetis based on three core quantitative signals: an extreme price drop creating a high-probability mean-reversion setup, elite operational efficiency, and a deeply discounted valuation.
- Deep Valuation Discount: Trading at just ~12x earnings with a 2.8% dividend yield ($2.12/share), the market is pricing this market-leading animal health giant as if its growth story is over—despite massive cash flow generation.
- Resilient Core Business Growth: Despite near-term US headwinds, Zoetis’s International segment grew ~17% and its Livestock division expanded ~12% organically in Q1 2026, demonstrating strong global pricing power.
- Fortress Financials: The company boasts elite fundamental metrics, including ~72% gross margins, an 18% Return on Assets (ROA), and an industry-leading balance sheet strength.
- Pipeline & Regulatory Catalysts: With more than 12 pipeline products advancing toward commercialization—including recent UK regulatory approval for Lenivia—catalysts are mounting to bridge the gap between market price and fair value.
Our AI models provide the same detailed rationale for every stock they select.
Want to see the full list? InvestingPro members can access July’s complete set of AI-powered stock picks (and their rationales) HERE - Now available at up to 60% off as part of our Summer Sale
Since launch in November 2023, that investor-grade edge has compounded into a remarkable +205.95% return, outpacing the S&P 500 by an impressive +178.21%.
These are real-world numbers, recorded since the official launch of our AI models in November 2023.
As part of our Summer Sale, you can secure an InvestingPro subscription for the LOWEST PRICE OF 2026.
InvestingPro members can access the complete July stock picks HERE.
Still not a member? Then here’s your chance to get the full list NOW:
How Investing.com’s AI-Powered Stock Picker Works
At the beginning of each month, our proprietary AI system evaluates thousands of global equities using a complex blend of historical data, valuation signals, and forward-looking growth metrics.
By processing more than 15 years of financial data across more than 150 quantitative models, the engine identifies up to 20 high-conviction stocks per strategy based on their projected medium-term upside potential.
Every month, these strategies undergo a strict rebalancing process. New opportunities are added, strong performers are retained, and stocks that no longer meet the criteria are removed.
To consistently track performance, each strategy utilises equal weighting across all selected stocks. While investors are free to adjust their own allocations, this structure provides a transparent benchmark for evaluating overall model performance.
The goal is to keep capital positioned in the companies showing the strongest combination of momentum, valuation, and business performance.
Disclaimer: Subscription prices mentioned in articles are accurate at the time of publication. We regularly test different offers for our members, which may vary by region.